Target intelligence / Profile preview

CD3 zeta chain

Molecular classification
Receptor subunit, Transmembrane protein
01

Overview

The CD3 zeta chain (CD247) is a crucial transmembrane subunit of the T-cell receptor (TCR)-CD3 complex. It plays a critical role in adaptive immune responses by transmitting signals from antigen recognition to intracellular signaling pathways via its immunoreceptor tyrosine-based activation motifs (ITAMs). The ζζ homodimer provides six ITAMs to the complex, making it central to downstream signaling. Low expression or absence impairs immune responses. It interacts with JAK3, protein unc119 homolog, and other proteins involved in immunological synapse formation. Microbial proteins such as HIV Nef can modulate these interactions, affecting immune function. It is expressed predominantly in lymphoid tissues and peripheral blood mononuclear cells.

Other names
T-cell surface glycoprotein CD3 zeta chainT-cell receptor T3 zeta chainCD247TCR-T3 zeta chainCluster of Differentiation 247
02

Mechanism of action

Not applicable (subunit of a receptor complex; direct targeting is rare)

03

Biological functions

Signal transductionImmune responseT-cell activationT-cell proliferationCytokine production
04

Disease associations

ImmunodeficiencyAutoimmune diseasesCancer (T-cell lymphomas)Infection
05

Safety considerations

ImmunosuppressionIncreased risk of infectionAutoimmunity (potential for off-target effects if directly targeted)
06

Biomarkers

CD3 zeta chain expression levels in T cellsPhosphorylation status of ITAM motifs

Beyond the preview

Go deeper on CD3 zeta chain.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD3 zeta chain.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call